- Home
- PANL vs INZY Comparison
PANL vs INZY Comparison
Compare PANL & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- INZY
- Stock Information
- Founded
- PANL 1996
- INZY 2015
- Country
- PANL United States
- INZY United States
- Employees
- PANL N/A
- INZY N/A
- Industry
- PANL Marine Transportation
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- PANL Consumer Discretionary
- INZY Health Care
- Exchange
- PANL Nasdaq
- INZY Nasdaq
- Market Cap
- PANL 289.9M
- INZY 321.4M
- IPO Year
- PANL N/A
- INZY 2020
- Fundamental
- Price
- PANL $5.96
- INZY $2.69
- Analyst Decision
- PANL Strong Buy
- INZY Strong Buy
- Analyst Count
- PANL 1
- INZY 7
- Target Price
- PANL N/A
- INZY $16.14
- AVG Volume (30 Days)
- PANL 169.9K
- INZY 333.8K
- Earning Date
- PANL 11-12-2024
- INZY 11-05-2024
- Dividend Yield
- PANL 6.68%
- INZY N/A
- EPS Growth
- PANL N/A
- INZY N/A
- EPS
- PANL 0.47
- INZY N/A
- Revenue
- PANL $521,238,386.00
- INZY N/A
- Revenue This Year
- PANL $6.40
- INZY N/A
- Revenue Next Year
- PANL $15.67
- INZY N/A
- P/E Ratio
- PANL $12.62
- INZY N/A
- Revenue Growth
- PANL 5.23
- INZY N/A
- 52 Week Low
- PANL $5.77
- INZY $2.63
- 52 Week High
- PANL $9.53
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- PANL 36.60
- INZY 15.50
- Support Level
- PANL $5.77
- INZY $4.02
- Resistance Level
- PANL $6.80
- INZY $4.74
- Average True Range (ATR)
- PANL 0.19
- INZY 0.27
- MACD
- PANL -0.05
- INZY -0.12
- Stochastic Oscillator
- PANL 20.39
- INZY 3.75
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.